Search Results

You are looking at 1 - 1 of 1 items for

  • Author: L Cabanie x
  • Refine by access: All content x
Clear All Modify Search
J Blahovec
Search for other papers by J Blahovec in
Google Scholar
PubMed
Close
,
Z Kostecka
Search for other papers by Z Kostecka in
Google Scholar
PubMed
Close
,
MC Lacroix
Search for other papers by MC Lacroix in
Google Scholar
PubMed
Close
,
L Cabanie
Search for other papers by L Cabanie in
Google Scholar
PubMed
Close
,
F Godeau
Search for other papers by F Godeau in
Google Scholar
PubMed
Close
,
J Mester
Search for other papers by J Mester in
Google Scholar
PubMed
Close
, and
F Cavaille
Search for other papers by F Cavaille in
Google Scholar
PubMed
Close

Amniotic fluid (AF) collected from ewes and goats at mid gestation displayed mitogenic activity in mouse fibroblasts. Upon fractionation of this material by size exclusion chromatography, the mitogenic activity was resolved into two peaks, whose activity was inhibited by an anti-IGF type 1 receptor blocking antibody. One of the peaks contained IGF-I and IGF-II (mature form), whereas the other contained high M(r) precursor forms of IGF-II. The presence in this latter fraction of IGF-binding proteins (IGFBP) suggests that the AF IGFBPs do not efficiently inhibit the mitogenic activity of the high M(r) forms of IGF-II. In agreement with this conclusion, exogenous IGFBP-1 failed to affect this activity. Analysis of IGF-II in sheep AF showed that the AF concentrations of both forms of IGF-II increased dramatically from mid pregnancy until 106-120 days of gestation, and fell thereafter. The amniotic IGFBPs followed a similar evolution. High M(r) forms of IGF-II were also found in human AF, with a pattern of electrophoretic migration different from that of sheep. We suggest that the precursor forms of IGF-II may play an important role in foetal development.

Free access